REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Romania SRL (Romania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Pfizer Romania SRL Profile Updated: May 22, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Romanian Download a sample report

Pfizer Romania SRL is a part of Pfizer Corporation, world premier biopharmaceutical company, with operations in more than 150 countries. Pfizer established its presence in Romania in 2004 and it is one of the strongest pharmaceutical companies on the local market. Company produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology, endocrinology, and neurology.

Headquarters
Strada Sos. Bucuresti-Ploiesti Nr. 172-176
Bucharest; Bucharest;

Contact Details: Purchase the Pfizer Romania SRL report to view the information.

Website: http://www.pfizer.ro

Basic Information
Total Employees:
Purchase the Pfizer Romania SRL report to view the information.
Registered Capital:
Purchase the Pfizer Romania SRL report to view the information.
Incorporation Date:
July 01, 2004
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
99.9999%
Purchase this report to view the information.
0.0001%
Company Performance
Financial values in the chart are available after Pfizer Romania SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
32.18%
Total operating revenue
32.22%
Operating profit (EBIT)
-39.06%
EBITDA
-37.83%
Net Profit (Loss) for the Period
-46.99%
Total assets
50.3%
Total equity
50.5%
Operating Profit Margin (ROS)
-4.87%
Net Profit Margin
-4.45%
Return on Equity (ROE)
-8.8%
Quick Ratio
-0.14%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?